Antares Pharma
Manufacturing · United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
United StatesWebsite
www.otrexup.comRevenue
<$5 MillionIndustry
About Antares Pharma
Is Antares Pharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Antares Pharma launches new products
Funding: Get notified immidiatlly once Antares Pharma has new funding data
Congratulate Masked Content for being promoted to Masked Content at Antares Pharma
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Antares Pharma recently announced quarterly report
Check if Antares Pharma has recently received funding, and reach out quickly before it becomes old news!
Antares Pharma, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Antares Pharma is spiking on competitors!
Click to see if Antares Pharma had a recent Job posting/layoffs
Recommended Actions
Find VP level buyers at Antares Pharma
Find 3 more new buyers
Compare Similar Companies to Antares Pharma
Compare insights from companies similar to Antares Pharma, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Antares Pharma
Company Profile Activity
Activity Insights
Antares Pharma is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Antares Pharma is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Antares Pharma.
Antares Pharma Tech Stack
A closer look at the technologies used by Antares Pharma
Antares Pharma News & Media
Assertio Holdings, Inc. Announces the Acquisition of Otrexup® (methotrexate) a Drug Device Combination from Antares Pharma, Inc.
Trailing 12 Month Reported Revenues of Otrexup Were $15.5 Million Assertio will Pay Antares $18.0 Million Upfront and an Additional $26.0 Million in Deferred Payments Raises Full Year Net Product Sales and Non-GAAP Adjusted EBITDA Guidance LAKE FOREST, Ill., Dec. 15, 2021 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc., (“Assertio” or “the Company”) (Nasdaq: ASRT), a leading commercial pharmaceutical company bringing differentiated products to patients, today announced it has acquired Otrexup (metho
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Antares Pharma
Otter Pharmaceuticals specializes in the development and distribution of Otrexup, a single-dose auto-injector containing methotrexate. This product is designed for the treatment of severe, active rheumatoid arthritis in adults and polyarticular juvenile idiopathic arthritis in children, as well as for managing severe psoriasis in adults when other... Read More